Adc Therapeutics Sa
(ADCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2008 | 10-2007 | 12-2006 | 10-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 631,400 | 520,200 | N/A | 142,200 | N/A |
| Marketable Securities | N/A | 61,600 | N/A | 395,400 | N/A |
| Receivables | 240,600 | 204,100 | N/A | 193,100 | N/A |
| Inventories | 162,700 | 169,600 | N/A | 165,400 | N/A |
| Other current assets | 8,000 | 20,800 | 0 | 15,100 | 0 |
| TOTAL | $1,077,400 | $1,008,200 | $N/A | $942,700 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 177,100 | 198,100 | N/A | 206,400 | N/A |
| Investments And Advances | 0 | 113,800 | 0 | 10,700 | 0 |
| Intangibles | 520,400 | 360,300 | 0 | 380,500 | 0 |
| Other Non-Current Assets | 146,100 | 84,400 | 0 | 71,100 | 0 |
| TOTAL | $843,600 | $756,600 | $N/A | $668,700 | $N/A |
| Total Assets | $1,921,000 | $1,764,800 | $N/A | $1,611,400 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 99,100 | 89,000 | 0 | 88,200 | 0 |
| Accrued Expenses | 94,800 | 97,200 | N/A | 75,000 | N/A |
| TOTAL | $278,000 | $474,100 | $N/A | $263,900 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 650,700 | 200,600 | N/A | 400,000 | N/A |
| Other Non-Current Liabilities | 78,800 | 82,500 | 0 | 74,000 | 0 |
| TOTAL | $728,800 | $283,100 | $N/A | $474,000 | $N/A |
| Total Liabilities | $1,006,800 | $757,200 | $N/A | $737,900 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,447 | 117,582 | N/A | 117,264 | N/A |
| Common Shares | 23,500 | 23,500 | N/A | 23,500 | N/A |
| Retained earnings | -491,500 | -450,900 | N/A | -557,200 | N/A |
| Other shareholders' equity | -14,100 | 2,700 | 0 | -10,200 | 0 |
| TOTAL | $914,200 | $1,007,600 | $N/A | $873,500 | $N/A |
| Total Liabilities And Equity | $1,921,000 | $1,764,800 | $0 | $1,611,400 | $0 |